News

1. Creative Biolabs Highlights Integrated Bispecific ADC Development Services for Biparatopic Programs

   Creative Biolabs, a global CRO specializing in antibody-drug conjugates (ADCs), is highlighting its integrated bispecific and biparatopic ADC development capabilities.

2. MyLabScope Reaches 55 Laboratories in Nigeria Pilot as It Builds a Pay-as-You-Go Diagnostic Network for Africa

   The platform is lowering the cost of laboratory digitalization while expanding patient booking, preventive health services, QR-verified results and diaspora-supported care.

3. Creative Biolabs Integrates Immunology and Microfluidic Solutions to Support Biotherapeutics Research

   Creative Biolabs boosts biotherapeutics research by combining specialized immunology assays with advanced microfluidics to help researchers profile immune responses and build flexible, fit‑for‑purpose workflows.

4. Creative Biolabs Targets Key Barriers in Lipid-Based Delivery

   Creative Biolabs expands functionalized lipid-based delivery system development capabilities, helping researchers address persistent challenges in targeting, carrier stability, biological responsiveness, and controlled payload release.

5. Health Canada Clears Updated Clinical Trial Protocol for Redsenol-1 Plus

   Clinical Trial Update on Redsenol-1 Plus for Cancer-Related Fatigue Research

6. Creative Biolabs Expands Advanced Single-Cell Multi-Omics and RNA Sequencing Solutions to Support Biomedical Discovery

   Creative Biolabs has expanded its single-cell analysis capabilities to support increasingly complex biomedical research applications.

7. Veedma Launches Free Doctor-Reviewed Lab Analysis for Men's Hormone Health

   Men can turn recent lab results into a personalized clinical report from a licensed doctor and understand the cause before considering treatment.

8. DM Clinical Research Marks 20 Years of Advancing Clinical Research

   20 Years of Impact: Expanding Patient Access and Accelerating Innovation

9. Creative Biolabs Integrates Microfluidics and Electrochemical Biosensors to Accelerate Next-Generation POCT Diagnostics

   Creative Biolabs has expanded its development platform by integrating advanced chip-based fluidics with electronic detection architectures.

10. The Power of Evidence-Led Strategy: Stelios Tzellos, PhD, on Why Scientific Thinking Should Drive Oncology Market Planning

    Stelios Tzellos explains why scientific understanding, not data alone, leads to more accurate pharmaceutical strategy.